IBEX COO sells 10,819 shares at $40.07

IBEX Ltd (IBEX) disclosed that Chief Operating Officer David Martin Afdahl sold 10,819 common shares on September 14, 2026 at a weighted average price of $40.07 per share, in transactions reported as made under a Rule 10b5-1 plan dated June 8, 2026.

Rhea-AI Filing Summary

IBEX Ltd (IBEX) disclosed that Chief Operating Officer David Martin Afdahl sold 10,819 common shares on September 14, 2026 at a weighted average price of $40.07 per share, in transactions reported as made under a Rule 10b5-1 plan dated June 8, 2026. Following these sales, he directly holds 129,187 common shares of IBEX.

Insider Trade Summary 10b5-1

Net Seller: 10,819 shares

Net Sell 1 txn

Insider Afdahl David Martin

Role Chief Operating Officer

Sold 10,819 shs ($433K)

Type	Security	Shares	Price	Value
Sale	Common Shares F1, F2	10,819	$40.0668	$433K

Holdings After Transaction: Common Shares — 129,187 shares (Direct)

Footnotes (2)

1. F1. Sales made pursuant to the Reporting Person's 10b5-1 Plan dated June 8, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $40.00 to $40.29; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 10,819 shares Weighted average sale price: $40.07 per share Post-transaction holdings: 129,187 shares +2 more

5 metrics

Shares sold 10,819 shares Common shares sold by the COO on September 14, 2026

Weighted average sale price $40.07 per share Average price for the September 14, 2026 share sales

Post-transaction holdings 129,187 shares Common shares directly held by the COO after the sale

Trade price range $40.00–$40.29 per share Range of prices for individual trades included in the reported sale

Rule 10b5-1 plan date June 8, 2026 Date of the trading plan under which the sales were made

Key Terms

Rule 10b5-1 Plan, weighted average sales price, open market or private transaction

3 terms

Rule 10b5-1 Plan regulatory

"Sales made pursuant to the Reporting Person's 10b5-1 Plan dated June 8, 2026."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average sales price financial

"the price reported above reflects the weighted average sales price"

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) report for its COO?

IBEX reported that Chief Operating Officer David Martin Afdahl sold 10,819 common shares on September 14, 2026 at a weighted average price of $40.07 per share, through transactions reported as made under a Rule 10b5-1 plan dated June 8, 2026.

How many IBEX (IBEX) shares does the COO hold after the reported sale?

After the reported sale, Chief Operating Officer David Martin Afdahl directly holds 129,187 common shares of IBEX. This figure reflects his direct ownership position immediately following the September 14, 2026 transactions.

At what price were the IBEX (IBEX) shares sold in this insider transaction?

The reported sale by IBEX’s Chief Operating Officer had a weighted average sales price of $40.07 per share, with individual trade prices ranging from $40.00 to $40.29, as disclosed in the filing footnote.

Was the IBEX (IBEX) COO’s share sale made under a Rule 10b5-1 trading plan?

Yes. The filing states that the sales were made pursuant to the reporting person’s Rule 10b5-1 plan dated June 8, 2026, indicating the transactions followed a pre-arranged trading plan.

How many IBEX (IBEX) shares did the COO sell in total in this Form 4?

The Chief Operating Officer sold a total of 10,819 common shares of IBEX in the reported transactions on September 14, 2026, according to the Form 4 disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 05:55 PM Accepted by SEC EDGAR 09/15/2026 - 05:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Afdahl David Martin

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20006

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/14/2026		S(1)		10,819	D	$40.0668(2)	129,187	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales made pursuant to the Reporting Person's 10b5-1 Plan dated June 8, 2026.

2. This transaction was executed in multiple trades at prices ranging from $40.00 to $40.29; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)